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KENNAWAY, Kennaway and Warren (1944) found that injection of certain
carcinogenic substances, including 1:2:5:6-dibenzanthracene, caused an increase
in the concentration of ascorbic acid in the liver of mice, whilst some non-
careinogenic, chemically related substances (naphthalene, anthracene, phen-
anthrene) did not show this effect.
In an investigation ofthe growth-inhibitory action ofthe carcinogenic hydro-
carbon 1:2:5:6-dibenzanthracene (Elson and Warren, 1947) it was found that
the inhibition of rat body growth and of the growth of Walker Rat carcinoma
256 (Elson and Haddow, 1947) by this substance is dependent on the protein
content of the diet of the animals. On a 20 per cent protein diet oneintraperi-
toneal injection of 500 mg./kg. 1:2:5:6-dibenzanthracene in the rat usually
results in little growth inhibition for about the first 14 days, after which the
animals at varying intervals lose weight and die. On a 10 per cent protein diet
after the same dose of the carcinogen, immediate inhibition of growth occurs
and persists for a prolonged period, usually until the death of the animal.
In considering the cause of the rise in liver ascorbic acid brought about by
1:2:5:6-dibenzanthracene, it appeared possible that this was a result ofthegrowth-
inhibitory action of the compound. There was some evidence (Elson, unpub-
lished communication) that the growth inhibition was accompanied by a fall in
the succinic dehydrogenase component of the succinoxidase enzyme system of
the liver. Since the cytochrome oxidase component of this enzyme system is
capable of rapid oxidation of ascorbic acid, it seemed possible that the rise in
ascorbic acid after 1:2:5:6-dibenzanthracene might be the result ofless destruction
by such oxidation occurring owing to the decreased content of the oxidizing
enzyme. The dependence of the growth-inhibiting action of the carcinogen on
diet offered an opportunity for investigation of this idea, since if the suggestion
that the rise in liver ascorbic acid is a consequence of the growth inhibition is
correct, it would not be expected to occur in animals maintained on the 20 per
cent protein diet until after the animal had begun to lose weight. Estimations
of liver ascorbic acid have been carried out in rats maintained on 20, 10 and
5 per cent protein diets and treated with 1:2:5:6-dibenzanthracene.EFFECT OF DIBIENZANTHRACENE ON ASCORBIC ACID OF LIVER 149
EXPERIMKFAL.
Estimation of ascorbic acid.
This was carried out by the method described previously by Kennaway
et al. (1944).
Diet.
The 20 per cent and 10 per cent protein diets were the same as those described
by Elson and Warren (1947), and the 5 per cent protein diet the same as that
described by Elson, Goulden and Warren (1947). The dry diets were made into
a "dough" by mixing with a little water. The animals were kept in separate
cages and fed amounts of diet in excess of their daily consumption. They were
weighed every 2 or 3 days.
High and lowprotein tabls.
In later experiments it was found necessary to estimate the amount of food
consumed by each rat, and in order to facilitate this 25 per cent and 5 percent
protein diets were made up in 5 g. tablets in the shape of cylinders of approxi-
mately 3 cm. diameter and 0-5 cm. high. This necessitated replacement of
some of the starch in the original diets by cane sugar and glucose in order to
obtain a firm tablet. The composition of these tablets is given in Table I.
TABLE I.-Composition of 25 per cent and 5 per cent Protein Tablets.
Prol
Casein (light white-Glaxo Laboratories Ltd.)
Starch (maize) . . . .
Sucrose . . ..
Glucose . . . . .
Margarine
Bemax (Vitamins Ltd.) . .
Salt mixture (Glaxo Laboratories Ltd.)
Chalk . . . . . .
Cod liver oil . . . .
Vitamin concentrate (aneurin 0 06%, riboflavin
0.4% in aqueous solution) .
Percentage Composition.
tein25percent. Protein5percent.
25 . 5
18 . 34
30 . 42
16 . 8
5 . 5
2-5 . 2-5
1 . 1
0-5 . 0-5
1
100
1
100
100
The daily ration of each rat was usually 3 tablets (15 g.), and by weighing
the remains the next day the food consumption could be determined with a fair
degree of accuracy, since the tablets were found not to change appreciably in
weight after exposure in air, and very little loss by crumbling occurred during
eating.
1:2:5:6-Dibenzanthracene for injection was dissolved at a concentration of
50mg. per c.c. in arachis oil by heating. The solution was cooled quicklywhilst
stirring with a glass rod, and the resulting mixture ofpartly dissolved and partly
suspended dibenzanthracene used for intraperitoneal injection.L. A. ELSON, E. L. KENNAWAY AND M. M. TIPLER
RESULTS.
The effects of 1:2:5:6-dibenzanthracene (500 mg./kg. i.p.) on the liver ascorbic
acid ofrats maintained on 20, 10 and 5per cent protein diets are shown in Tables
II, mI and IV. From the control experiments, in which only arachis oil was
injected,.it is seen that the variation of the protein content of the diet itself has
practically no influence on the level of ascorbic acid in the liver. The mean
values are 231 Lg. per g. liver for the animals maintained on the 20 per cent
protein diet, 209 4Lg. for those on the 10 per cent protein diet and 222 pg. for
those on the 5 per cent protein diet. The injection of dibenzanthracene causes
an increase in the mean values for ascorbic acid content of 40 per cent (324 pg.
TABLE 11.-AscorbicAcid Content of the Liver of Rats Maintained on 20per cent.
Protein Diet and Treated with 1:2:5:6-Dibenzanthracene (D.B.A.).
A. Controis (1 c.c. aracMs oil.)
Days after Body weight Liver weight % Ascorbic acid yg
injection. (g.). of body weight. per g. liver.
7 . 105 . 6-44 . 224
7 . 109 . 6- 72 . 203
7 . 120 . 6-0 . 230
10 . 145 . 5-0 . 278
10 . 153 . 5-46 . 238
10 . 146 . 5-24 . 215
Mean . 130 . 5-81 . 231
B. D.B.A. (500 mg./kg. in 1 c.c. arachis oil).
7 . 98-5 . 6-9 . 264
7 . 121 . 7-7 . 262
7 . 139 . 5-6 . 385
7 . 169 . 5- 7 . 380
7 . 139 . 6- 9 . 367
10 . 158 . 7-65 . 310
10 . 138 . 5-9 . 300
Mean . 137 . 6-34 324
per g. liver) in the 20 per cent protein diet animals, 66 per cent (349 pg. per g.
liver) in the 10 per cent protein diet animals, and 21 per cent (269 ig. per g.
liver) in those maintained on the 5 per cent protein diet.
From Figure 1 it is clear that in the animals maintained on the 20 per
cent protein diet the liver ascorbic acid had already increased 7 days after injec-
tion and before the growth inhibition occurred; also, the succinic dehydrogenase
activity (Thunberg technique) of the livers of rats No. 1, 2 and 3 was found not
to be significantly lower than that of control rats maintained on the same diet
and injected with arachis oil only.
Referring again to Tables II,m1 and IV it is seen that the maximum increase
in liver ascorbic acid caused by 1:2:5:6-dibenzanthracene occurs in the animals
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maintained on the 10 per cent protein diet. It has been suggested (Elson and
Warren, 1947) that the actual growth-inhibiting agent is a metabolic product of
dibenzanthracene,andthattherateofabsorptionandmetabolismofthecarcinogen
is thus related to the total metabolism of the animal, which is, in turn, con-
trolled by the level of protein in the diet. Thus a dynamic equilibrium exists
between the rate ofproduction of the toxic metabolite and the total metabolism
Ascorbic acid
gper g.livr
367
380
385
300
310
Days
FIG. 1.-Growth rates of individual rats maintained on 20 per cent protein diet before and
after treatment (shownby arrow) with 1:2:5:6-chbenzanthracene (500mg./kg.), and ascorbic
acid contents found for the liver of each rat when killed (K). Figures in parentheses give
the initial weight of the rat.
of the animal. Judging by the magnitude of the growth-inhibiting effect of
dibenzanthracene, this equilibrium appears to reach a maximum in the animals
maintained on a diet of about 10 per cent protein content. The animals fed
the 5 per cent protein diet grow only very slowly, but the effect ofdibenzanthra-
cene on them is not to make them lose weight, as would beexpectedifthe magni-
tude of the growth inhibition was proportionate to that observed in animals
maintained on the 10 per cent protein diet. This smaller effect is presumably
related to the lower total metabolism of the 5 per cent protein diet animals, and
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TAEBL mIII.-Ascorbic Acid Content of the Liver ofRats Maintained on 10 per
cent Protein Diet and Treated with 1:2:5:6-Dibenzanthracene (D.B.A.).
A. Contro (1 c.c. arachi/oil).
Days after Body weight Liver weight % Ascorbic acid pLg
injection. (g.). ofbody weight. per g. liver.
8 . 142 . 4-24 . 280
8 . 120 . 3- 82 . 250
11 . 120 . 5-57 . 192
12 . 108 . 4-46 . 210
14 . 139 . 4-55 . 149
15 . 167 . 4-63 . 171
Mean . 133 . 4-55 . 209
B. D.B.A. (500 mg./lg. in 1 c.c. arachis oil.)
8 . 115 . 6-52 . 374
8 . 122 . 5-8 . 374
11 . 129 . 5-8 . 313
12 . 120 . 6-5 . 357
13 . 107 . 6-8 . 384
14 . 161 . 6-2 . 318
15 . 136 . 7- 7 . 325
Mean . 127 . 6-47 . 349
it must be supposed that the smaller increase in liver ascorbic acid in these
animals is also connected with the same cause.
If the growth-inhibiting effect of dibenzanthracene is caused by inhibition of
proteinsynthesis, it seemspossible that energy normally used for proteinsynthesis
could, in the inhibited animals, be diverted to increased carbohydrate meta-
bolism, andthat the increase in liver ascorbic acid is associated with this increase.
Observations of rats treated with growth-inhibiting carcinogens indicated no
marked decrease in food consumption corresponding with the lower growth rate,
and the animals usually appear very active in movement, etc.
Experiments were carried out in which the daily food consumption of
individual rats was measured, before and after treatment with 1:2:5:6-dibenz-
anthracene. The food in these experiments consisted of the 25 per cent and
5 per cent protein tablets previously described (Table I). The results are given
in Fig. 2 and 3. The growth rate of the rats fed on the 25 per cent protein
tablets before treatment with dibenzanthracene was not as high as is usually
obtained when the animals are fed the ordinary 20 per cent protein diet (Fig. 1),
probably because less of the "tablet" food was consumed. This was reflected
in the reaction of the rats to the dibenzanthracene.
Instead ofproducing no immediate effect on the growth rate, as in the case of
those amals fed.20 per cent protein diet (Fig. 1), a considerable growth inhibi-
tion was observed. Immediately following the injection there was a drop in
fqod intake lasting for one or two days, followed by rapid reeovery of appetite
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TABLE IV.-Ascorbic Acid Content of the Liver of Rat8 Maintained on 5 per cent
Protein Diet and Treated with 1:2:5:6-Dibenzanthracene (D.B.A.).
A. Contros (1 c.c. arachis oil).
Days after Bo<dy weight Liver weight % Ascorbic acid jg injection. (g.). ofbody weight. per g. liver.
7 . 100 . 5-61 . 267
7 . 96 . 7- 15 . 227
8 . 91 . 3 70 . 230
8 . 103 . 5-92 . 220
11 . 116 . 5'0 . 177
13 . 115 . 6-86 . 250
14 . 108 . 4-33 . 254
15 . 114 . 4-49 . 145
Mean . 105 . 5-38 . 222
B. DJBA. (500 mg./lkg. in 1 c.c. arachis oil).
7 . 100 . 7-0 . 251
7 . 76 . 6-5 . 294
7 . 75 . 6-36 . 315
7 . 96 . 7-15 . 305
8 . 102 . 6-0 . 253
11 . 111 . 7-6 . 252
14 . 85 . 7-15 . 236
15 . 118 . 4-81 . 292
15 . 116 . 6-8 . 195
15 . 109 . 5-8 . 298
Mean . 99 . 6-52 . 269
(Fig. 2). The rats then reacted either by assuming an apparently prolonged
lower rate of food intake (rat No. 1 and 2) which was accompanied by a rapid
loss of weight, or the food intake remained at very little below the pre-injection
level, although complete inhibition of growth and even loss of weight occurred
(rats No. 3 and 4). In the case of rat No. 5, although complete inhibition of
growth occurred, and at one time actual loss ofweight, the food intake, after the
initial drop, rose steadily to a value higher than the level before administration
of dibenzanthracene
At the time the animals were killed for determination of liver ascorbic acid
the actual degree ofgrowth inhibition was greater than the maximum previously
obtained with the 10 per cent protein diet animals. The level of liver ascorbic
acid was also the highest obtained (mean 386 y per g. liver).
The rats maintained on the 5 per cent protein tablets also showed a drop in
food intake immediately following the injection of 1:2:5:6-dibenzanthracene, but
soon regained their initial level (Fig. 3). This level was then retained or in some
cases slightly increased for the duration of the experiment. The effect of the
dibenzanthracene on the growth rate of the animals was not nearly as great as
with the animals fed the 25 per cent protein tablets,and the level ofliverascorbic
acid was also not so high (mean 344 y per g. liver).L. A. ELSON, E. L. KENNAWAY AND M. M. TIPLER
DISCUSSION.
Rats maintained on a 20per cent protein diet show anincrease in liver ascorbic
acid within 7 days of injection of 1:2:5:6-dibenzanthracene, before any marked
inhibition of growth or decrease in liver succinoxidase occurs. This does not
support the idea that the rise in liver ascorbic acid results from a decreased
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FIG. 2.-Growth rate, food intake, and liver ascorbic acid of rats maintained on 25 per cent
protein tablets and injected (shown by arrow) with 1:2:5:6-dibenzanthracene (500 mg./kg.
Lp.). Figures in parentheses give the initial weight of the rat.
destruction ofthe vitamin owing to the lowered level ofoxidizing enzymes, being
thus an indirect effect of the growth-inhibitory action of the carcinogen.
Comparison of the magnitude of the increase in liver ascorbic acid caused by
dibenzanthracene in rats maintained on 20, 10 and 5 per cent protein diets
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suggests rather that the increase is roughly directly proportional to the amount
of growth inhibition obtained. The degree of growth inhibition is dependent on
an equilibrium being established between the rate at which the animal is metabo-
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FIG. 3.-Growth rate, food intake, and liver ascorbic acid of rats maintained on 5 per cent
protein tablets and injected (shown by arrow) with 1:2:5:6-dibenzanthracene (500 mg./kg.
i.p.). Figures in parentheses give the initial weight of the rat.
lizing the hydrocarbon and the rate at which it is synthesing protein necessary
for growth. In animals maintained on a 20 per cent protein diet there is a rapid
rate of general metabolism, and hence presumably of metabolism of the dibenz-
anthracene to a "toxic" metabolite which exerts its growth-inhibitory action
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by interference with protein synthesis. In these animals, however, the high
protein diet ensures an ample supply of all amino-acids needed for synthesis of
tissueproteins, and thus, because ofthe rapid rate ofprotein synthesis, theeffect
of the inhibitor is not immediately apparent, and the animal continues to grow
until accumulation of toxic metabolite eventually results in rapid loss in weight
followed by death (Elson and Warren, 1947). In animals maintained on low
protein diets, although the rate of production of the "toxic" metabolite may
not be so high, the animals' rate ofprotein synthesis is already restricted by the
limitedsupply ofamino-acids in the diet, and on treatment withdibenzanthracene
an immediate effect on growth is observed.
It seems possible, therefore, that the increase in liver ascorbic acid in rats
treated with dibenzanthracene may be directly related to the inhibitory action
of the substance on protein metabolism and synthesis. In these animals energy
normally used for protein synthesis may be diverted to increased carbohydrate
metabolism,andtherise in liverascorbic acid may be associated withthisincrease.
Theassessment ofthe amount offood eatenfollowinginjectionwiththecarcinogen
lends some support to this idea. After an initial short period ofloss ofappetite
the animal may react by assuming a somewhat lower level offoodintake, or may
continue to eat much the same or an even greater amount offood daily, although
growth may be completely inhibited.
Under these latter conditions a very profound change in the basal metabolism
of the animal must presumably have taken place, and considerable investigation
will be necessary before the significance of this change can be fully asessed.
At present, pending further investigation, it can only be suggested that the rise
in liver ascorbic acid may well be one ofthe results ofthis altered metabolism.
SUMMARY.
The increase in liver ascorbic acid produced by treatment with 1:2:5:6-
dibenzanthracene in rats maintained on 20, 10 and 5 per cent protein diets has
been studied. In animals fed 20 per cent protein diet liverascorbic acid increases
before any marked growth-inhibition is observed, and the increase is thus not
an indirect consequence ofthe inhibition ofgrowth.
The growth-inhibition is not merely the result of a lowered intake of food.
The animals may react to treatment with dibenzanthracene by maintaining
or even increasing their daily food consumption, although growth is completely
inhibited. This suggests that a profound change in basal metabolism must have
taken place, and the rise in liver ascorbic acid may be associated withthischange.
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